TREM2 and neurodegenerative disease

New England Journal of Medicine

Volumn 369, Issue 16, 2013, Pages 1568-

  Bird, Thomas D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; AMYLOID PLAQUE; AUTOSOMAL RECESSIVE DISORDER; BRAIN DISEASE; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; GENE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LETTER; MEMBRANOUS LIPODYSTROPHY; PRIORITY JOURNAL; SENILE PLAQUE; TREM2 GENE; ANIMAL; GENETICS; MISSENSE MUTATION; MUTATION; NOTE;

IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN;

ALZHEIMER DISEASE; ANIMALS; HUMANS; MEMBRANE GLYCOPROTEINS; MUTATION; MUTATION, MISSENSE; RECEPTORS, IMMUNOLOGIC;

EID: 84885828745     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1306509     Document Type: Letter

References (3)

1. Neumann H, Daly MJ. Variant TREM2 as risk factor for Alzheimer's disease. N Engl J Med 2013;368:182-4.
2. Bird TD, Koerker RM, Leaird BJ, Vlcek BW, Thorning DR. Lipomembranous polycystic osteodysplasia (brain, bone, and fat disease): a genetic cause of presenile dementia. Neurology 1983;33:81-6.
3. Paloneva J, Manninen T, Christman G, et al. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am J Hum Genet 2002;71:656-62. [Erratum, Am J Hum Genet 2003;72:225.]